San Francisco, CA, United States of America

Richard Thomas Beresis

This inventor holds 6 USPTO granted patents and 7 published patent applications. Top assignees: Dynavax Technologies Corporation, University of California, Shangpharma Innovation Inc.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Thomas Beresis. Retrieved from https://idiyas.com/inventor/richard-thomas-beresis-k976xxg8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Richard Thomas Beresis

Introduction

Richard Thomas Beresis is an accomplished inventor based in San Francisco, CA. With a total of five patents to his name, he has made significant contributions to the fields of biochemistry and pharmaceuticals. His inventions demonstrate a commitment to advancing medical technology and improving human health.

Latest Patents

Among his latest patents, the first is titled "STRAD-binding agents and uses thereof." This patent discloses various compounds designed for binding the STRAD pseudokinase, providing promising applications in therapeutic contexts.

Another noteworthy invention is related to "Toll-like receptor antagonist compounds and methods of use." This invention focuses on compounds of a specific formula that act as antagonists of toll-like receptors such as TLR7, TLR8, and TLR9. These compounds play a crucial role in inhibiting immune responses and are valuable for treating diseases associated with undesirable immune activities.

Career Highlights

Richard Thomas Beresis has had a notable career, working with esteemed organizations such as the University of California and Dynavax Technologies Corporation. His experiences in these institutions have provided him with a robust foundation in research and innovation, allowing him to develop impactful solutions in his field.

Collaborations

Throughout his career, Beresis has collaborated with prominent colleagues, including Albert Frederick Candia III and Robert L. Coffman. These partnerships have fostered a collaborative spirit, which is essential for driving innovation and enhancing the scope of his research in the biopharmaceutical sector.

Conclusion

In summary, Richard Thomas Beresis embodies the spirit of innovation through his patented inventions and collaborative efforts in the scientific community. His work not only contributes to the advancement of medical science but also exemplifies the impact that dedicated inventors can have on society. As he continues to innovate, his future endeavors are sure to lead to even more groundbreaking discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…